ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2208

Novel Fluorescence Optical Imaging Scoring System of Inflammation in the Hand and Wrist Is in Patients with Rheumatoid Arthritis – Agreement with Ultrasonography and Sensitivity to Change

Mads Ammitzbøll-Danielsen1, Daniel Glinatsi1, Lene Terslev2 and Mikkel Østergaard3,4, 1Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Copenhagen Center for Arthritis Research, Copenhagen, Denmark, 2Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark, 3Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup Copenhagen Center for Arthritis Research, Copenhagen, Denmark, 4Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Assessment, imaging techniques, rheumatoid arthritis (RA) and ultrasound, Validity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Imaging of Rheumatic Diseases Poster III: Other Modalities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Fluorescence optical imaging (FOI) has been used for assessment of inflammation in the hands and has in several cross sectional studies been compared with US and MRI, but no validated scoring systems exist.

The aim was in a longitudinal study to validate a new and clinically feasible FOI scoring system for assessments of synovitis in RA hands by comparison with US and determining its sensitivity to change.

Methods:

46 RA patients eligible for initiation or intensification of disease modifying anti-rheumatic drugs and with ≥1 clinically swollen joint in the hand, were included and assessed by FOI, US and clinical assessment at baseline and 6 months. FOI image-sets of both wrists and hands were obtained using a Xiralite system unit. The patients received a bolus of i.v. indocyanine green (ICG) 10 seconds after starting the examination, which obtained 1 image/second for 6 minutes.

All FOI images were scored by two readers for synovitis at the wrist, MCP and PIP joint levels in both hands. The novel synovitis scoring is based on the assumption that inflamed tissue would demonstrate a more rapid enhancement than surrounding tissues. For each joint, the images were assessed sequentially from start to peak enhancement. Synovitis was defined as a sharply marginated enhancement with clear delineation from surrounding tissues and correct anatomical location, lasting ≥3 seconds. The width of the pathology fulfilling these criteria was compared to the width of the joint at the 3rd second of enhancement of that particular joint, and scored 0-3 for synovitis (total range 0–66) The readers were blinded to patient data, but not chronology, and had previously showed a high intra- and inter-reader agreement (ICC:0.70-0.92).

For US assessment, a GE Logiq E9 US unit with a high frequency linear 6-15 ML probe and with Doppler settings optimised for slow flow. Synovitis was scored from 0-3 for grey scale (GS) and Doppler using the OMERACT US synovitis scoring system by two trained assessors with a previously documented high intra- and inter-reader agreement (wKappa:0.88-0.95).

Agreement for status and change scores was assessed using single measure intraclass correlation coefficients (ICCs) and Spearman correlation coefficients (rho). Responsiveness was assessed using standardized response mean (SRM)

Results:

Baseline scores, change scores and their respective SRMs are presented in table. 1. The mean SRM was good for all parameters

ICC and rho between FOI and US total scores were low for both readers at baseline (range 0.3-0-4) (p<0.05), and low to moderate (range 0.31-0.54) (p<0.01) for change scores.

Conclusion:

A moderate correlation with US for change over time, and good responsiveness, were found for a new FOI scoring system. FOI may potentially prove useful for monitoring RA patients in clinical trials and practice.


Disclosure: M. Ammitzbøll-Danielsen, None; D. Glinatsi, None; L. Terslev, Danish Rheumatism Association, 2, 8,AbbVie Inc., Roche, Novartis, 8; M. Østergaard, None.

To cite this abstract in AMA style:

Ammitzbøll-Danielsen M, Glinatsi D, Terslev L, Østergaard M. Novel Fluorescence Optical Imaging Scoring System of Inflammation in the Hand and Wrist Is in Patients with Rheumatoid Arthritis – Agreement with Ultrasonography and Sensitivity to Change [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/novel-fluorescence-optical-imaging-scoring-system-of-inflammation-in-the-hand-and-wrist-is-in-patients-with-rheumatoid-arthritis-agreement-with-ultrasonography-and-sensitivity-to-change/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/novel-fluorescence-optical-imaging-scoring-system-of-inflammation-in-the-hand-and-wrist-is-in-patients-with-rheumatoid-arthritis-agreement-with-ultrasonography-and-sensitivity-to-change/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology